FCR001, an investigational cell therapy: Harnessing the power of immune tolerance in living kidney donor transplant from hla hla Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Post-transplant maintenance with chronic immunosuppression is the current standard of care to prevent renal graft rejection. However, this imposes significant burdens on patients and the health care system alike. There is a continued need for innovative research that improves both long-term patient and graft survival, as well as quality of life outcomes.n nThis video highlights the Talaris approach kidney transplant care utilizing FCR001, an investigational allogeneic cell therapy product. The
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)